SmokingNCT06693700
A Study Evaluating the Use of an Indoor Air Quality Monitor to Promote a Smoke-free Home
A study testing Indoor Air Quality Monitor AirGradient ONE in people with Smoking and Smoking Cessation, run by Memorial Sloan Kettering Cancer Center at 8 sites in United States.
Trial summary
The purpose of this study is to evaluate how using an indoor air quality monitor can promote a smoke-free home for cancer patients who are enrolled in MSK's Tobacco Treatment Program. Read more about this study
- Who is it for?
- Ages 18 years and olderHealthy volunteers can take part
- Conditions the study is for
- Smoking, Smoking Cessation, Smoking Reduction
- What is being tested?
- Indoor Air Quality Monitor AirGradient ONE
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 10 participants
- Where
- 8 sitesUnited States
- Study dates
- 14 Nov 2024to 14 Nov 2027
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Adult (aged >18 years) MSK patients as per the EHR
- Has been referred and enrolled in the MSK TTP and completed the initial counseling session as per the TTP clinical database
- Reports current (within the past 30 days) tobacco use (i.e., cigarettes and/or any other tobacco products) as per the TTP Intake form
- Must be English-speaking in the EHR
- Must be reachable by phone as per self-report
- Must have Wi-Fi available at home as per self-report
Who cannot join
- Patient reports that no smoking is allowed, by them or anyone else, in the home as per the TTP intake form and/or per self-report
Trial locations and contacts
8 sites in 1 country. Contact the study team or a site near you to ask about taking part.
8 sites in 1 country
United States8 sites, 8 recruiting
- Recruiting
Memorial Sloan Kettering Basking Ridge (Consent only)
Basking Ridge, New Jersey, 07920
Gleneara Bates-Pappas, PhD, LMSW, 212-610-0507
- Recruiting
Memorial Sloan Kettering Suffolk-Commack (Consent only)
Commack, New York, 11725
Gleneara Bates-Pappas, PhD, LMSW, 212-610-0507
- Recruiting
Memorial Sloan Kettering Westchester (Consent only)
Harrison, New York, 10604
Gleneara Bates-Pappas, PhD, LMSW, 212-610-0507
- Recruiting
Memorial Sloan Kettering Monmouth (Consent only)
Middletown, New Jersey, 07748
Gleneara Bates-Pappas, PhD, LMSW, 212-610-0507
- Recruiting
Memorial Sloan Kettering Bergen (Consent only)
Montvale, New Jersey, 07645
Gleneara Bates-Pappas, PhD, LMSW, 212-610-0507
- Not yet recruiting
City College of New York (Data Collection AND Data Analysis)
New York, New York, 10031
Prash Naidu, MD, pnaidu@ccny.cuny.edu
- Recruiting
Memorial Sloan Kettering Cancer Center (All Protocol Activities)
New York, New York, 10065
Gleneara Bates-Pappas, PhD,LMSW, 212-610-0507
- Recruiting
Memorial Sloan Kettering Nassau (Consent only)
Uniondale, New York, 11553
Gleneara Bates-Pappas, PhD, LMSW, 212-610-0507
About this study
Official title: Freedom to Breathe: Pilot Study Towards Achieving Environmental Justice for Cancer Patients and Their Families
The purpose of this study is to evaluate how using an indoor air quality monitor can promote a smoke-free home for cancer patients who are enrolled in MSK's Tobacco Treatment Program.
- Conditions
- Smoking, Smoking Cessation, Smoking Reduction, Smoking Habit, Smoking Behaviors, Smoking, Tobacco
- Being tested
- Indoor Air Quality Monitor AirGradient ONE
- Keywords
- smoking, smoking cessation, smoking reduction, smoking habit, smoking behaviors, smoking, tobacco, smoking, cigarette, smoking (tobacco) addiction, tobacco use, tobacco smoking, air quality, indoor air quality monitoring devices, 24-260, Memorial Sloan Kettering Cancer Center
- Medical subject headings
- Smoking, Smoking Cessation, Smoking Reduction, Tobacco Smoking, Cigarette Smoking, Behavior, Addictive, Tobacco Use
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Indoor Air Quality Monitor AirGradient ONEOther
Participants will be asked to set up an Indoor Air Quality Monitor AirGradient ONE (Model: I-9PSL) which is an award winning commercially available indoor air quality monitor designed to enable anyone to monitor their air quality in their home for about 60 days (8 weeks). Indoor air pollution levels within participating households will be measured using these AQMs.
| Study group | Role | What they receive |
|---|---|---|
| MSK Participants who are current smokers | Experimental | 10 MSK participants who are current smokers and receiving tobacco treatment will be enrolled. Receives: Other: Indoor Air Quality Monitor AirGradient ONE |
What is being measured
The primary outcome is the main question the study is designed to answer.
Percentage of participants using the air quality monitoring device for 14 consecutive days
Assess the feasibility and acceptability of collecting environmental data on biomarkers of household air quality (AQ) and smoke exposure using low-cost, AQMs as an intermediate endpoint of a smoke-free-home.
Measured: up to 8 weeks
Percentage of participants who attend the study-specific smoke-free workshop sessions
Assess the feasibility and acceptability of tobacco treatment adherence among individuals diagnosed with cancer.
Measured: Up to 8 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted18 Nov 2024
- Study start14 Nov 2024
- Primary completion14 Nov 2027 (estimated)
- Study completion14 Nov 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for SmokingStudies of the same condition, open and under way.
- More trials run by Memorial Sloan Kettering Cancer CenterThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Prevention
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 10 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Memorial Sloan Kettering Cancer Center
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Gleneara Bates-Pappas, PhD, LMSW, Principal investigator, Memorial Sloan Kettering Cancer Center
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06693700
- Sponsor's protocol ID
- 24-260
- Status last verified
- Aug 2026
- First submitted
- 14 Nov 2024
- Last updated
- 27 Aug 2026
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes: Memorial Sloan Kettering Cancer Center supports the international committee of medical journal editors (ICMJE) and the ethical obligation of responsible sharing of data from clinical trials. The protocol summary, a statistical summary, and informed consent form will be made available on clinicaltrials.gov when required as a condition of Federal awards, other agreements supporting the research and/or as otherwise required. Requests for deidentified individual participant data can be made beginning 12 months after publication and for up to 36 months post publication. Deidentified individual participant data reported in the manuscript will be shared under the terms of a Data Use Agreement and may only be used for approved proposals. Requests may be made to: crdatashare@mskcc.org.
Study at a glance
From the registry record, last updated by the sponsor on 27 Aug 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Freedom to Breathe: Pilot Study Towards Achieving Environmental Justice for Cancer Patients and Their Families
- ClinicalTrials.gov ID
- NCT06693700
- Acronym / sponsor ID
- 24-260
- Conditions
- Smoking, Smoking Cessation, Smoking Reduction, Smoking Habit, Smoking Behaviors, Smoking, Tobacco
- Keywords
- smoking, smoking cessation, smoking reduction, smoking habit, smoking behaviors, smoking, tobacco, smoking, cigarette, smoking (tobacco) addiction
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 10 participants (estimated)
- Lead sponsor
- Memorial Sloan Kettering Cancer CenterUniversity, hospital or other
- Study start
- 14 Nov 2024 (actual)
- Primary completion
- 14 Nov 2027 (estimated)
- Study completion
- 14 Nov 2027 (estimated)
- First posted
- 18 Nov 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The purpose of this study is to evaluate how using an indoor air quality monitor can promote a smoke-free home for cancer patients who are enrolled in MSK's Tobacco Treatment Program.
Study design
- Primary purpose
- Prevention
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| MSK Participants who are current smokers | Experimental | Other: Indoor Air Quality Monitor AirGradient ONE10 MSK participants who are current smokers and receiving tobacco treatment will be enrolled. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (6 listed)
- Adult (aged >18 years) MSK patients as per the EHR
- Has been referred and enrolled in the MSK TTP and completed the initial counseling session as per the TTP clinical database
- Reports current (within the past 30 days) tobacco use (i.e., cigarettes and/or any other tobacco products) as per the TTP Intake form
- Must be English-speaking in the EHR
- Must be reachable by phone as per self-report
Key exclusion criteria (1 listed)
- Patient reports that no smoking is allowed, by them or anyone else, in the home as per the TTP intake form and/or per self-report
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Indoor Air Quality Monitor AirGradient ONEParticipants will be asked to set up an Indoor Air Quality Monitor AirGradient ONE (Model: I-9PSL) which is an award winning commercially available indoor air quality monitor designed to enable anyone to monitor their air quality in their home for about 60 days (8 weeks). Indoor air pollution levels within participating households will be measured using these AQMs. | Other | MSK Participants who are current smokers |
Primary outcome
Percentage of participants using the air quality monitoring device for 14 consecutive days
Time frame: up to 8 weeks
Assess the feasibility and acceptability of collecting environmental data on biomarkers of household air quality (AQ) and smoke exposure using low-cost, AQMs as an intermediate endpoint of a smoke-free-home.
Percentage of participants who attend the study-specific smoke-free workshop sessions
Time frame: Up to 8 weeks
Assess the feasibility and acceptability of tobacco treatment adherence among individuals diagnosed with cancer.
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 27 Aug 2026.
- Memorial Sloan Kettering Cancer CenterLink provided by the sponsor.
- Individual participant dataSharing planned: Yes. Memorial Sloan Kettering Cancer Center supports the international committee of medical journal editors (ICMJE) and the ethical obligation of responsible sharing of data from clinical trials. The protocol summary, a statistical summary, and informed consent form will be made available on clinicaltrials.gov when required as a condition of Federal awards, other agreements supporting the research and/or as otherwise required. Requests for deidentified individual participant data can be made beginning 12 months after publication and for up to 36 months post publication. Deidentified individual participant data reported in the manuscript will be shared under the terms of a Data Use Agreement and may only be used for approved proposals. Requests may be made to: crdatashare@mskcc.org.
Related trials for Smoking
Not yet recruiting
The Effects of Manual Acupuncture on Superoxide Dismutase Enzyme Activity and Questionnaire of Smoking Urges-Brief Scores in Active Smokers: A Randomized Controlled Trial
Superoxide Dismutase, Acupuncture
Recruiting
Smoking Cessation in Patients With Cancer
Cancer, Tobacco Use
RecruitingPhase 1
Nicotinic Receptor Genetic Variation and Alcohol Reward
Alcohol Drinking
Enrolling by invitationObservational study
Using Smartwatches to Monitor Smoking in Real-life Situations
Smoking
Not yet recruiting
Effectiveness Of Project EX: A Classroom-Based Smoking Prevention And Cessation Intervention Program
Focus of the Study is Smoking Cessation and Prevention, Smoking Prevention
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Gleneara Bates-Pappas, PhD, LMSW principal investigator
Memorial Sloan Kettering Cancer Center
8 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Indoor Air Quality Monitor AirGradient ONE in people with Smoking and Smoking Cessation, run by Memorial Sloan Kettering Cancer Center at 8 sites in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 6 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 27 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 8 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Gleneara Bates-Pappas, PhD, LMSW (212-610-0507, batespag@mskcc.org), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Percentage of participants using the air quality monitoring device for 14 consecutive days (time frame: up to 8 weeks). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Aug 2026.